Cargando…
Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review
BACKGROUND: Drug-resistant tuberculosis burdens fragile health systems in sub-Saharan Africa (SSA), complicated by high prevalence of HIV. Several African countries reported large gaps between estimated incidence and diagnosed or treated cases. Our review aimed to identify barriers and facilitators...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333807/ https://www.ncbi.nlm.nih.gov/pubmed/32616481 http://dx.doi.org/10.1136/bmjgh-2019-002280 |
_version_ | 1783553823000756224 |
---|---|
author | Oga-Omenka, Charity Tseja-Akinrin, Azhee Sen, Paulami Mac-Seing, Muriel Agbaje, Aderonke Menzies, Dick Zarowsky, Christina |
author_facet | Oga-Omenka, Charity Tseja-Akinrin, Azhee Sen, Paulami Mac-Seing, Muriel Agbaje, Aderonke Menzies, Dick Zarowsky, Christina |
author_sort | Oga-Omenka, Charity |
collection | PubMed |
description | BACKGROUND: Drug-resistant tuberculosis burdens fragile health systems in sub-Saharan Africa (SSA), complicated by high prevalence of HIV. Several African countries reported large gaps between estimated incidence and diagnosed or treated cases. Our review aimed to identify barriers and facilitators influencing diagnosis and treatment for drug-resistant tuberculosis (DR-TB) in SSA, which is necessary to develop effective strategies to find the missing incident cases and improve quality of care. METHODS: Using an integrative design, we reviewed and narratively synthesised qualitative, quantitative and mixed-methods studies from nine electronic databases: Medline, Global Health, CINAHL, EMBASE, Scopus, Web of Science, International Journal of Tuberculosis and Lung Disease, PubMed and Google Scholar (January 2006 to June 2019). RESULTS: Of 3181 original studies identified, 55 full texts were screened, and 29 retained. The studies included were from 6 countries, mostly South Africa. Barriers and facilitators to DR-TB care were identified at the health system and patient levels. Predominant health system barriers were laboratory operational issues, provider knowledge and attitudes and information management. Facilitators included GeneXpert MTB/RIF (Xpert) diagnosis and decentralisation of services. At the patient level, predominant barriers were patients being lost to follow-up or dying due to lengthy diagnostic and treatment delays, negative public sector care perceptions, family, work or school commitments and using private sector care. Some patient-level facilitators were HIV positivity and having more symptoms. CONCLUSION: Case detection and treatment for DR -TB in SSA currently relies on individual patients presenting voluntarily to the hospital for care. Specific interventions targeting identified barriers may improve rates and timeliness of detection and treatment. |
format | Online Article Text |
id | pubmed-7333807 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-73338072020-07-07 Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review Oga-Omenka, Charity Tseja-Akinrin, Azhee Sen, Paulami Mac-Seing, Muriel Agbaje, Aderonke Menzies, Dick Zarowsky, Christina BMJ Glob Health Original Research BACKGROUND: Drug-resistant tuberculosis burdens fragile health systems in sub-Saharan Africa (SSA), complicated by high prevalence of HIV. Several African countries reported large gaps between estimated incidence and diagnosed or treated cases. Our review aimed to identify barriers and facilitators influencing diagnosis and treatment for drug-resistant tuberculosis (DR-TB) in SSA, which is necessary to develop effective strategies to find the missing incident cases and improve quality of care. METHODS: Using an integrative design, we reviewed and narratively synthesised qualitative, quantitative and mixed-methods studies from nine electronic databases: Medline, Global Health, CINAHL, EMBASE, Scopus, Web of Science, International Journal of Tuberculosis and Lung Disease, PubMed and Google Scholar (January 2006 to June 2019). RESULTS: Of 3181 original studies identified, 55 full texts were screened, and 29 retained. The studies included were from 6 countries, mostly South Africa. Barriers and facilitators to DR-TB care were identified at the health system and patient levels. Predominant health system barriers were laboratory operational issues, provider knowledge and attitudes and information management. Facilitators included GeneXpert MTB/RIF (Xpert) diagnosis and decentralisation of services. At the patient level, predominant barriers were patients being lost to follow-up or dying due to lengthy diagnostic and treatment delays, negative public sector care perceptions, family, work or school commitments and using private sector care. Some patient-level facilitators were HIV positivity and having more symptoms. CONCLUSION: Case detection and treatment for DR -TB in SSA currently relies on individual patients presenting voluntarily to the hospital for care. Specific interventions targeting identified barriers may improve rates and timeliness of detection and treatment. BMJ Publishing Group 2020-07-02 /pmc/articles/PMC7333807/ /pubmed/32616481 http://dx.doi.org/10.1136/bmjgh-2019-002280 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Original Research Oga-Omenka, Charity Tseja-Akinrin, Azhee Sen, Paulami Mac-Seing, Muriel Agbaje, Aderonke Menzies, Dick Zarowsky, Christina Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review |
title | Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review |
title_full | Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review |
title_fullStr | Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review |
title_full_unstemmed | Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review |
title_short | Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review |
title_sort | factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-saharan african countries: a mixed-methods systematic review |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333807/ https://www.ncbi.nlm.nih.gov/pubmed/32616481 http://dx.doi.org/10.1136/bmjgh-2019-002280 |
work_keys_str_mv | AT ogaomenkacharity factorsinfluencingdiagnosisandtreatmentinitiationformultidrugresistantrifampicinresistanttuberculosisinsixsubsaharanafricancountriesamixedmethodssystematicreview AT tsejaakinrinazhee factorsinfluencingdiagnosisandtreatmentinitiationformultidrugresistantrifampicinresistanttuberculosisinsixsubsaharanafricancountriesamixedmethodssystematicreview AT senpaulami factorsinfluencingdiagnosisandtreatmentinitiationformultidrugresistantrifampicinresistanttuberculosisinsixsubsaharanafricancountriesamixedmethodssystematicreview AT macseingmuriel factorsinfluencingdiagnosisandtreatmentinitiationformultidrugresistantrifampicinresistanttuberculosisinsixsubsaharanafricancountriesamixedmethodssystematicreview AT agbajeaderonke factorsinfluencingdiagnosisandtreatmentinitiationformultidrugresistantrifampicinresistanttuberculosisinsixsubsaharanafricancountriesamixedmethodssystematicreview AT menziesdick factorsinfluencingdiagnosisandtreatmentinitiationformultidrugresistantrifampicinresistanttuberculosisinsixsubsaharanafricancountriesamixedmethodssystematicreview AT zarowskychristina factorsinfluencingdiagnosisandtreatmentinitiationformultidrugresistantrifampicinresistanttuberculosisinsixsubsaharanafricancountriesamixedmethodssystematicreview |